(Q47863483)

6 February 2018

title

The Unfolded Protein Response in Immunogenic Cell Death and Cancer Immunotherapy (English)

1 reference

6 February 2018

1 reference

1 reference

2

1 reference

6 February 2018

author name string

Nicole Rufo

series ordinal

1

1 reference

6 February 2018

Patrizia Agostinis

series ordinal

3

1 reference

6 February 2018

publication date

2 August 2017

1 reference

6 February 2018

published in

Trends in cancer

1 reference

6 February 2018

volume

3

1 reference

6 February 2018

issue

9

1 reference

6 February 2018

page(s)

643-658

1 reference

6 February 2018

Protein folding and quality control in the ER

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2017.07.002

Endoplasmic reticulum stress: cell life and death decisions.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2017.07.002

Targeting the unfolded protein response in disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2017.07.002

Signal integration in the endoplasmic reticulum unfolded protein response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2017.07.002

Endoplasmic reticulum stress-sensing mechanisms in yeast and mammalian cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2017.07.002

Controlling the unfolded protein response-mediated life and death decisions in cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2017.07.002

ER-stress-induced transcriptional regulation increases protein synthesis leading to cell death.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2017.07.002

Endoplasmic reticulum stress induces ligand-independent TNFR1-mediated necroptosis in L929 cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2017.07.002

Emerging functions of the unfolded protein response in immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2017.07.002

Endoplasmic reticulum stress in immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2017.07.002

Endoplasmic Reticulum Stress and the Hallmarks of Cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2017.07.002

Targeting the hallmarks of cancer with therapy-induced endoplasmic reticulum (ER) stress.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2017.07.002

Stress responses from the endoplasmic reticulum in cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2017.07.002

Emerging tale of UPR and cancer: an essentiality for malignancy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2017.07.002

Cancer Microenvironment and Endoplasmic Reticulum Stress Response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2017.07.002

Immune modulation by ER stress and inflammation in the tumor microenvironment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2017.07.002

ER Stress and Angiogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2017.07.002

Hallmarks of Cancer: The Next Generation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2017.07.002

The determinants of tumour immunogenicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2017.07.002

Type 2 cytokines: mechanisms and therapeutic strategies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2017.07.002

Translational repression mediates activation of nuclear factor kappa B by phosphorylated translation initiation factor 2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2017.07.002

Cancer-related inflammation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2017.07.002

Coupling of stress in the ER to activation of JNK protein kinases by transmembrane protein kinase IRE1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2017.07.002

Activation of the Akt-NF-kappaB pathway by subtilase cytotoxin through the ATF6 branch of the unfolded protein response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2017.07.002

ER stress activates the NLRP3 inflammasome via an UPR-independent pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2017.07.002

ER stress induces NLRP3 inflammasome activation and hepatocyte death.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2017.07.002

Immunity, Inflammation, and Cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2017.07.002

Autocrine IL-6 signaling: a key event in tumorigenesis?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2017.07.002

Increased Th17 cells in the tumor microenvironment is mediated by IL-23 via tumor-secreted prostaglandin E2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2017.07.002

Endoplasmic reticulum stress stimulates the expression of cyclooxygenase-2 through activation of NF-kappaB and pp38 mitogen-activated protein kinase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2017.07.002

Tumor stress inside out: cell-extrinsic effects of the unfolded protein response in tumor cells modulate the immunological landscape of the tumor microenvironment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2017.07.002

Transmission of endoplasmic reticulum stress and pro-inflammation from tumor cells to myeloid cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2017.07.002

A stressful microenvironment: opposing effects of the endoplasmic reticulum stress response in the suppression and enhancement of adaptive tumor immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2017.07.002

Cancer as an overhealing wound: an old hypothesis revisited

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2017.07.002

Apoptotic cell clearance: basic biology and therapeutic potential.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2017.07.002

Immunogenic and tolerogenic cell death

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2017.07.002

Molecular characteristics of immunogenic cancer cell death.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2017.07.002

Immunogenic cell death and DAMPs in cancer therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2017.07.002

Calreticulin exposure dictates the immunogenicity of cancer cell death

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2017.07.002

Danger signalling during cancer cell death: origins, plasticity and regulation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2017.07.002

Activation of the NLRP3 inflammasome in dendritic cells induces IL-1beta-dependent adaptive immunity against tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2017.07.002

Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2017.07.002

Pathogen response-like recruitment and activation of neutrophils by sterile immunogenic dying cells drives neutrophil-mediated residual cell killing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2017.07.002

Chemotherapy-induced antitumor immunity requires formyl peptide receptor 1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2017.07.002

Cancer cell-autonomous contribution of type I interferon signaling to the efficacy of chemotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2017.07.002

Molecular and Translational Classifications of DAMPs in Immunogenic Cell Death

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2017.07.002

Vaccination with Necroptotic Cancer Cells Induces Efficient Anti-tumor Immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2017.07.002

Contribution of RIP3 and MLKL to immunogenic cell death signaling in cancer chemotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2017.07.002

A novel pathway combining calreticulin exposure and ATP secretion in immunogenic cancer cell death

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2017.07.002

Newcastle disease virotherapy induces long-term survival and tumor-specific immune memory in orthotopic glioma through the induction of immunogenic cell death

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2017.07.002

Coxsackievirus B3 is an oncolytic virus with immunostimulatory properties that is active against lung adenocarcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2017.07.002

Induction of immunogenic cell death by chemotherapeutic platinum complexes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2017.07.002

Caspase-2 and oxidative stress underlie the immunogenic potential of high hydrostatic pressure-induced cancer cell death.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2017.07.002

The ER Stress Sensor PERK Coordinates ER-Plasma Membrane Contact Site Formation through Interaction with Filamin-A and F-Actin Remodeling.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2017.07.002

Mechanisms of pre-apoptotic calreticulin exposure in immunogenic cell death

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2017.07.002

Multiple roles for the actin cytoskeleton during regulated exocytosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2017.07.002

Trial Watch: Immunogenic cell death inducers for anticancer chemotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2017.07.002

Immunological metagene signatures derived from immunogenic cancer cell death associate with improved survival of patients with lung, breast or ovarian malignancies: A large-scale meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2017.07.002

Biomarkers of immunogenic stress in metastases from melanoma patients: Correlations with the immune infiltrate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2017.07.002

Concepts and mechanisms underlying chemotherapy induced immunogenic cell death: impact on clinical studies and considerations for combined therapies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2017.07.002

Resistance to anticancer vaccination effect is controlled by a cancer cell-autonomous phenotype that disrupts immunogenic phagocytic removal

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2017.07.002

Prognostic and Predictive Value of DAMPs and DAMP-Associated Processes in Cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2017.07.002

CD47 blockade triggers T cell-mediated destruction of immunogenic tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2017.07.002

Genomic correlates of response to CTLA-4 blockade in metastatic melanoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2017.07.002

Cancer immunology. Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2017.07.002

The evolution of checkpoint blockade as a cancer therapy: what's here, what's next?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2017.07.002

Immunogenic Chemotherapy Sensitizes Tumors to Checkpoint Blockade Therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2017.07.002

Immunological Effects of Conventional Chemotherapy and Targeted Anticancer Agents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2017.07.002

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2017.07.002

Improved clinical outcome in indolent B-cell lymphoma patients vaccinated with autologous tumor cells experiencing immunogenic death.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2017.07.002

Dendritic cell vaccines based on immunogenic cell death elicit danger signals and T cell-driven rejection of high-grade glioma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2017.07.002

Combined evaluation of LC3B puncta and HMGB1 expression predicts residual risk of relapse after adjuvant chemotherapy in breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2017.07.002

Immunogenic tumor cell death induced by chemoradiotherapy in patients with esophageal squamous cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2017.07.002

Serum HMGB1 is a predictive and prognostic biomarker for oncolytic immunotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2017.07.002

Calreticulin exposure on malignant blasts predicts a cellular anticancer immune response in patients with acute myeloid leukemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2017.07.002

Expression of calreticulin is associated with infiltration of T-cells in stage IIIB colon cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2017.07.002

An immunosurveillance mechanism controls cancer cell ploidy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2017.07.002

Activation of the unfolded protein response is associated with favorable prognosis in acute myeloid leukemia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2017.07.002

The expression of the endoplasmic reticulum stress sensor BiP/GRP78 predicts response to chemotherapy and determines the efficacy of proteasome inhibitors in diffuse large b-cell lymphoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2017.07.002

The unfolded protein response: controlling cell fate decisions under ER stress and beyond

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2017.07.002

PERK-dependent activation of JAK1 and STAT3 contributes to endoplasmic reticulum stress-induced inflammation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2017.07.002

The miR-17 ∼ 92 Cluster: A Key Player in the Control of Inflammation during Rheumatoid Arthritis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2017.07.002

IRE1α induces thioredoxin-interacting protein to activate the NLRP3 inflammasome and promote programmed cell death under irremediable ER stress.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2017.07.002

Autophagy-dependent anticancer immune responses induced by chemotherapeutic agents in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2017.07.002

Consensus guidelines for the detection of immunogenic cell death

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2017.07.002

10.1016/J.TRECAN.2017.07.002

7 January 2021

Identifiers

DOI

1 reference

6 February 2018

1 reference

6 February 2018